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Objective:  The  primary  outcome  of  this  study  was  to  evaluate  the  effect  of  adding  sufentanil  to
hyperbaric  bupivacaine  on  duration  of  sensory  blockade  of  spinal  anesthesia  in  chronic  opioid
users in  comparison  with  non-addicts.
Methods:  Sixty  patients  scheduled  for  orthopedic  surgery  under  spinal  anesthesia  were  allo-
cated into  four  groups:  group  1  (no  history  of  opium  use  who  received  intrathecal  hyperbaric
bupivacaine  along  with  1  mL  saline  as  placebo);  group  2  (no  history  of  opium  use  who  received
intrathecal  bupivacaine  along  with  1  mL  sufentanil  [5  g]);  group  3  (positive  history  of  opium  use
who received  intrathecal  bupivacaine  along  with  1  mL  saline  as  placebo)  and  group  4  (positive
history of  opium  use  who  received  intrathecal  bupivacaine  along  with  1  mL  sufentanil  [5  g]).
The onset  time  and  duration  of  sensory  and  motor  blockade  were  measured.
Results:  The  duration  of  sensory  blockade  in  group  3  was  120  ±  23.1  min  which  was  signiﬁcantly
less than  other  groups  (G1  =  148  ±  28.7,  G2  =  144  ±  26.4,  G4  =  139  ±  24.7,  p  =  0.007).  The  duration
of motor  blockade  in  group  3  was  145  ±  30.0  min  which  was  signiﬁcantly  less  than  other  groups
(G1 =  164  ±  36.0,  G2  =  174  ±  26.8,  G4  =  174  ±  24.9,  p  =  0.03).
Conclusions:  Addition  of  5  g  intrathecal  sufentanil  to  hyperbaric  bupivacaine  in  chronic  opioid
users lengthened  the  sensory  and  motor  duration  of  blockade  to  be  equivalent  to  blockade
measured  in  non-addicts.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This
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Avaliac¸ão  do  tempo  de  bloqueio  da  raquianestesia  com  bupivacaína  a  hiperbárica
0,5%,  com  ou  sem  sufentanil,  em  usuários  crônicos  de  opioides:  um  estudo  clínico
randômico
Resumo
Objetivo:  Avaliar  o  efeito  da  adic¸ão  de  sufentanil  à  bupivacaína  hiperbárica  na  durac¸ão  do
bloqueio sensorial  da  raquianestesia  em  usuários  crônicos  de  opioides  em  comparac¸ão  com  não
adictos.
Métodos: Foram  distribuídos  em  quatro  grupos  60  pacientes  agendados  para  cirurgia  ortopédica
sob raquianestesia:  Grupo  1  (sem  história  de  uso  de  ópio,  recebeu  bupivacaína  hiperbárica
intratecal  juntamente  com  1  mL  de  soluc¸ão  salina  como  placebo);  Grupo  2  (sem  história  de  uso
de ópio,  recebeu  bupivacaína  intratecal  juntamente  com  1  mL  de  sufentanil  [5  g]);  Grupo  3
(com história  de  uso  de  ópio,  recebeu  bupivacaína  intratecal  juntamente  com  1  mL  de  soluc¸ão
salina como  placebo)  e  Grupo  4  (Com  história  de  uso  de  ópio,  recebeu  bupivacaína  intratecal
juntamente  com  1  mL  de  sufentanil  [5  g]).  O  tempo  de  início  e  a  durac¸ão  dos  bloqueios  sensitivo
e motor  foram  registrados.
Resultados:  A  durac¸ão  do  bloqueio  sensorial  no  Grupo  3  foi  de  120  ±  23,1  min,  um  tempo
signiﬁcativamente  menor  que  nos  outros  grupos  (G1  =  148  ±  28,7,  G2  =  144  ±  26,4,  G4  =  139
± 24,7,  p  =  0,007).  A  durac¸ão  do  bloqueio  motor  no  Grupo  3  foi  de  145  ±  30,0  min,  um  tempo
signiﬁcativamente  menor  que  nos  outros  grupos  (G1  =  164  ±  36.0,  G2  =  174  ±  26.8,  G4  =  174  ±
24,9; p  =  0,03).
Conclusões:  A  adic¸ão  de  5  g  de  sufentanil  intratecal  à  bupivacaína  hiperbárica  em  usuários
crônicos de  opioides  aumentado  a  durac¸ão  dos  bloqueios  sensorial  e  motor  de  forma  equivalente
ao bloqueio  avaliado  em  não  adictos.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este























two  hours  new  patients  were  replaced  in  the  study.Introduction
Motor  vehicle  trauma  may  result  in  lower  limb  fractures
requiring  operative  intervention,  and  may  occur  in  the
setting  of  opium  abuse.  Since  spinal  anesthesia  is  a pop-
ular  anesthetic  technique  in  lower  limb  surgeries,1,2 the
characteristics  of  spinal  anesthesia  in  this  population  are
important.
In the  studied  geographical  region,  Iran,  determining
a  deﬁnite  estimate  of  prevalence  and  incidence  of  sub-
stance  abuse  is  not  possible  due  to  social  stigmatization
along  with  legal  restrictions.  Between  different  substances,
most  commonly,  opioids  are  abused  and  inhalation  the
most  frequent  route  of  abuse.3 Furthermore,  many  of
the  victims  of  motor  vehicle  accidents  are  chronic  opi-
oid  users  and  the  accidents  are  the  result  of  driver’s  drug
abuse.4
The  sensory  and  motor  blockade  behavior  of  spinal
anesthesia  in  long-term  chronic  opioid  users  has  not  been
previously  studied  thoroughly.
In  a  study  conducted  by  Dabbagh  et  al.,  duration  of  spinal
anesthesia  with  hyperbaric  bupivacaine  in  chronic  opium
abusers  undergoing  lower  extremity  orthopedic  surgery  was
studied.  It  was  shown  that  the  duration  of  sensory  block  was
much  shorter  in  chronic  opium  abusers  compared  with  non-
abusers.5 The  hypothesis  of  our  study  was  that  the  duration
of  spinal  anesthesia  in  chronic  opioid  users  is  shorter  than
non-addict  patients  and  adding  intrathecal  sufentanil  can
increase  spinal  anesthesia  blockade  time  in  chronic  opioid
user.
p
aThe  primary  outcome  of  this  study  was  to  evaluate  the
ffect  of  adding  sufentanil  to  intrathecal  bupivacaine  on
uration  of  sensory  and  motor  blockade  of  spinal  anesthe-
ia  chronic  opioid  users  compared  to  non-addict  patients.
he  onset  of  sensory  and  motor  blockade  was  considered
econdary  outcomes.
aterials and methods
he  study  protocol  was  approved  by  the  Institutional  Ethics
ommittee  of  Tehran  University  of  Medical  Sciences,  and
fter  a thorough  detailed  explanation  of  the  nature  of  the
tudy  to  the  participants,  an  informed,  written  consent  was
btained  from  all  the  patients.
Sixty  American  Society  of  Anesthesiologist  physical  status
ASA)  class  I  and  II,  male  and  current  smoker  patients,  aged
etween  18  and  60,  who  were  scheduled  for  elective  lower
imb  orthopedic  surgery  under  spinal  anesthesia  (lasting  less
han  2  h)  were  enrolled  in  this  randomized,  double-blinded
linical  trial.  Patients  with  any  contraindications  to  spinal
nesthesia,  patients  with  addiction  to  any  substance  other
han  opium  and  cigarettes,  and  patients  with  history  of  car-
iac,  respiratory,  or  psychological  disease  were  not  entered
n  the  study.  It  had  been  considered  that  in  instances  of
ailed  spinal  anesthesia  or  when  surgery  took  longer  thanPrior  to  spinal  anesthesia  all  the  required  drugs  were  pre-
ared  by  an  anesthetist  who  was  neither  involved  in  the











































































































he  anesthesiologist  and  the  patients  were  blinded  to  group
ssignment.  The  anesthesiologist  who  performed  the  sub-
rachnoid  block  and  documented  the  sensory  levels  was
linded  to  the  patient’s  group.  On  arrival  to  the  operating
oom,  based  on  a  previously  generated  computer  randomiza-
ion  list,  patients  were  assigned  into  groups.  Group  1  (n  =  15)
ad  no  history  of  chronic  opium  use  and  received  intrathecal
yperbaric  bupivacaine  along  with  1  mL  saline  as  placebo.
roup  2  (n  =  15)  had  no  history  of  opium  use  and  received
ntrathecal  hyperbaric  bupivacaine  along  with  1  mL  sufen-
anil  (5  g;  n  =  15).  Group  3  (n  =  15)  had  a  positive  history
f  chronic  opium  use  and  received  intrathecal  hyperbaric
upivacaine  along  with  1  mL  saline  as  placebo.  Lastly,  group
 (n  =  15)  had  a  positive  history  of  chronic  opium  use  and
eceived  intrathecal  hyperbaric  bupivacaine  along  with  1  mL
ufentanil  (5  g).  The  bupivacaine  ampoules  (20  mg/4  mL)
ontained  320  mg  glucose  monohydrate.
Chronic  opium  use  was  deﬁned  as  recurrent  and  continu-
us  daily  consumption  of  1--2  g  of  opium  via  inhalation  route
or  at  least  one  year  without  a  cessation  until  the  day  of
urgery  based  on  the  histories  that  reported  by  the  patients.
atients  with  poly  substance  abuse  were  not  enrolled  in
he  study.  None  of  the  patients  had  any  intention  to  stop
pium  use  before  surgery  and  all  the  patients  were  advised
o  continue  using  their  typical  inhaled  opium  until  the  day  of
urgery  in  the  preoperative  visit.  Patients  were  given  their
aily  doses  of  inhaled  opium  on  the  day  of  surgery.  In  order  to
ule  out  opium  use  in  the  control  groups  and  conﬁrm  opium
se  in  the  study  group,  in  all  patients,  an  opiate  urine  test
as  performed.
Pre-operative  pain  management  protocol  was  the  same
or  all  the  patients.  The  patients  received  intermittent
every  6  h)  intravenous  apotel  (15  mg/kg)  (Intravenous
aracetamol  1000  mg/6.7  mL,  UNI-PHARMA  S.A.)  if  the  VAS
core  for  pain  was  higher  than  3.  Diclofenac  suppository  was
dministered  to  patients  who  had  pain  despite  intravenous
potel  administration.
Two  hours  before  surgery,  patients  received  1  mg  oral
orazepamas  premedication.  On  arrival  in  the  operating
oom,  standard  monitoring  was  established  (electrocardiog-
aphy,  noninvasive  blood  pressure,  pulse  oximetry  and  heart
ate)  and  oxygen  was  delivered  via  a  venture  facemask  at
 rate  of  3  L/min.  An  18-gauge  cannula  was  inserted  into  a
ein  on  the  dorsum  of  the  non-dominant  hand  and  a  bolus
ose  of  lactated  ringer  solution  7  mL/kg  was  administered.
hen,  with  the  patient  in  the  lateral  decubitus  position  a
using  an  aseptic  technique,  a  25-gauge  pencil  point  needle
as  inserted  intrathecally  via  a  midline  approach  into  the
3--L4  or  L4--L5  interspaces.
Patients  in  groups  1  and  3  received  intrathecally  3  mL  of
.5%  hyperbaric  bupivacaine  along  with  1  mL  saline.  Patients
n  groups  2  and  4  were  administered  3  mL  of  0.5%  hyperbaric
upivacaine  and  1  mL  (5  g)  of  sufentanil.  All  the  solutions
ere  administered  at  a  rate  of  2  mL/s.  All  patients  were
laced  in  supine  position  following  drug  injection.  To  record
he  onset  time  and  duration  of  sensory  and  motor  block,
ensory  level  was  assessed  using  a  pinprick  test  every  minute
or  10  min  and  then  every  10  min  for  120  min  after  the  end  of
njection  (zero  time).  The  motor  blockade  was  assessed  by
he  Bromage  Scale  (Grade  I:  free  movement  of  the  legs  and
eet,  Grade  II:  just  able  to  ﬂex  knees  with  free  movement  of
eet,  Grade  III:  unable  to  ﬂex  knees,  but  with  free  movement
1
1
(M.  Sadeghi  et  al.
f  feet,  Grade  IV:  unable  to  move  legs  or  feet).6 The  onset
ime  of  sensory  blockade  was  deﬁned  as  the  time  from  drug
dministration  until  bilateral  T8  level  of  sensory  blockade
as  achieved.  The  duration  of  sensory  block  was  considered
s  the  time  from  the  highest  level  of  sensory  blockade  until
 segment  regressions  were  observed.7
The  onset  time  of  motor  blockade  was  deﬁned  as  the
ime  from  drug  injection  until  a  grade  IV  Bromage  score  was
chieved.  The  duration  of  motor  block  was  considered  as
he  time  from  full  intensity  motor  blockade  until  a  Bromage
rade  I score  was  documented.
If  any  of  the  patients  complained  of  pain  at  any  time
uring  the  operation,  this  was  considered  to  be  a  failed
pinal  anesthesia,  and  general  anesthesia  was  then  induced
mmediately.
Hypotension  was  deﬁned  as  a  decrease  in  systolic  blood
ressure  to  less  than  90  mmHg  or  25%  less  than  base-
ine.  Hypotension  was  treated  with  bolus  doses  of  10  mg
ntravenous  ephedrine.  Bradycardia  (HR  <  50  beat/min)  was
reated  by  0.5  mg  IV  atropine.  In  cases  of  nausea  or  vomit-
ng  without  the  presence  of  bradycardia,  patients  received
0  mg  IV  metoclopramide.
It  was  determined  that  a  sample  size  of  15  participants  in
ach  group  would  be  sufﬁcient  to  detect  a  30  min  difference
n  sensory  block  time,  estimating  an  SD  of  28  min,  a  power
f  80%,  and  a  signiﬁcance  level  of  5%.
Statistical  analysis  of  the  data  was  performed  using  SPSS
or  windows,  release  17.5  (SPSS.  Inc).  The  distribution  of
ata  was  evaluated  using  the  Kolmogorov--Smirnov  test.
ge,  weight,  height,  and  duration  of  surgery  followed  a
ormal  distribution  and  were  analyzed  by  using  one-way
nalysis  of  variance  (ANOVA)  and  Tukey  post  hoc  tests.
owever,  sensory  and  motor  onset  time  and  duration  of
lockades  did  not  follow  normal  distribution.  Their  compar-
sons  were  performed  using  Mann--Whitney  test.  Two  tailed
-values  <0.05  were  considered  statistically  signiﬁcant.
esults
ixty  male  patients  were  randomized.  There  were  no  proto-
ol  violations  and  all  patients  were  included  in  the  analysis.
The  basic  characteristics  of  the  participants,  including
ge,  weight,  height,  the  duration  of  the  surgery  and  the
uration  of  anesthesia  were  similar  in  groups  and  are  pre-
ented  in  Table  1.  Different  types  of  orthopedic  surgeries
erformed  in  each  group  are  presented  in  Table  2.  There
ere  no  statistical  differences  between  the  types  of  surg-
ries  in  groups.  The  highest  level  of  sensory  blockade  in  each
roup  is  presented  in  Table  3.  Urinary  opium  test  was  posi-
ive  in  all  the  patients  in  groups  3  and  4  and  was  negative  in
ll  patients  in  groups  1  and  2.
There  was  no  signiﬁcant  difference  in  the  mean  onset
ime  of  the  sensory  blockade  (group  1  =  2.8  ±  1.7  min,
roup  2  =  2.4  ±  0.9  min,  group  3  =  3.4  ±  1.1  min,  group
 =  2.3  ±  1.4  min,  p  =  0.12)  or  the  motor  blockade
group  1  =  5.5  ±  3.0  min,  group  2  =  4.1  ±  1.3  min,  group
 =  5.8  ±  2.3  min,  group  4  =  5.3  ±  2.3  min,  p  =  0.19)  in  groups.
The  duration  of  sensory  blockade  in  group  3 was
20  ±  23.1  min,  which  was  signiﬁcantly  shorter  than  group
 (148  ±  28.7  min),  group  2  (147  ±  26.4  min)  and  group  4
139  ±  24.7)  (one-way  analysis  of  variance  test,  p  =  0.03).
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Table  1  Demographic  data  of  the  patients  and  duration  of  surgery.
Group  1
(n =  15)
Group  2
(n =  15)
Group  3
(n =  15)
Group  4
(n =  15)
Age  (years)a 34.4  ±  10.8  35.7  ±  8.3  40.3  ±  9.3  36.8  ±  5.8
Weight (kg)a 74.4  ±  13.2  70.0  ±  15.4  73.6  ±  8.4  73.6  ±  14.3
Height (cm)a 174.4  ±  10.2  174.2  ±  8.5  172.6  ±  6.3  171.4  ±  8.9
Duration of  surgery  (min)a 110  ±  28.9  99.3  ±  22.9  91.3  ±  30.3  97.3  ±  30.7
a There was no signiﬁcant difference in groups.
Table  2  Types  of  surgeries.
Group  1
(n =  15)
Group  2
(n =  15)
Group  3
(n =  15)
Group  4
(n =  15)
Femoral  fracture  4  5  4  7
Ankle  fracture  6  7  5  5
Tibia/ﬁbula
fracture
5 3  6  3
Table  3  Highest  level  of  sensory  block  achieved  in  each
group.
Group  1
(n =  15)
Group  2
(n =  15)
Group  3
(n =  15)
Group  4
(n =  15)



























o7th  thoracic  level 6  7  5  6
8th  thoracic  level 4  4  5  4
The  duration  of  sensory  blockade  was  signiﬁcantly  dif-
ferent  between  groups.  The  duration  of  motor  blockade
in  group  3  (145  ±  30.0  min)  which  was  signiﬁcantly  less
than  group  1  (164  ±  36.0  min),  group  2  (174  ±  26.8  min)  and
group  4 (174  ±  24.9  min)  (one-way  analysis  of  variance  test,
p  =  0.007).  There  was  no  statistical  difference  in  duration
of  sensory  and  motor  blockade  between  groups  1,  2  and  4
(Tukey  post  hoc  test)  (Table  4).
DiscussionThe  present  study  illustrated  that  the  duration  of  sensory
and  motor  blockade  in  spinal  anesthesia  with  intrathe-
cal  hyperbaric  bupivacaine  is  shorter  in  chronic  opioid





Table  4  Sensory  and  motor  blockade  time,  sensory  and  motor  du
Group  1
(n =  15)
Sensory  blockade  onset  timea 2.8  ±  1.7  
Motor blockade  onset  timea 5.5  ±  3.0  
Duration of  sensory  blockade  148  ±  28.7  
Duration of  motor  blockade  164  ±  36.0  
a There was no signiﬁcant difference in groups.
b There was a signiﬁcant difference in groups, p < 0.05.nesthetic  solution  increased  the  duration  of  sensory  and
otor  blockade  in  chronic  opioid  users.
Adding  5  g  of  sufentanil  to  the  local  anesthetic  solution
ad  no  effect  on  the  duration  of  sensory  and  motor  blockade
n  non-addicts.  No  difference  in  sensory  or  motor  blockade
nset  time  was  observed  in  any  of  the  groups.
Few  data  are  available  in  the  literature  regarding  the
ehavior  of  regional  anesthesia  in  chronic  opioid  users.
hen  a  thorough  search  of  the  known  databases  such  as
SI  and  PubMed  was  done,  no  study  regarding  the  effect  of
dding  opioids  to  local  anesthetics  in  spinal  anesthesia  in
hronic  opioid  users  was  found.
As  previously  mentioned,  in  a  study  conducted  by  Dab-
agh  et  al.,  it  was  observed  that  a  shorter  duration  of
ensory  and  motor  blockade  occurred  with  intrathecally
dministration  of  bupivacaine  in  chronic  opioid  users  when
ompared  to  non-addicts.  It  was  proposed  that  a  cross-
olerance  may  exist  between  local  anesthetics  and  opioid
ompounds  at  the  level  of  spinal  neurons.5 In  another  study
onducted  by  the  same  team,  the  effect  of  intrathecal
dministration  of  lidocaine  in  spinal  anesthesia  was  stud-
ed  in  chronic  opioid  users  with  similar  outcomes,  including
horter  sensory  and  motor  blockade  during  spinal  anesthe-
ia  inchronic  opioidusers.8 However,  the  effect  of  adding  an
pioid  compound  to  local  anesthetics  in  spinal  anesthesia  in
rder  to  modify  this  shortened  duration  was  not  examined
y  either  of  these  studies.
In  a  survey,  it  was  concluded  that  intrathecal  sufentanil
roduces  a  similar  quality  but  shorter  duration  of  analgesia
n  cocaine-abuser  parturient.9
The  mechanism  of  modiﬁcation  of  opioid  effect  in  chronic
pioid  users  is  not  completely  clear.  This  effect  may  be  par-
ially  explained  by  the  down-regulation  of  opioid  receptors
r  a  cross  tolerance  between  opioids  and  local  anesthetic
eceptors,  yet  it  is  so  far  off  to  clearly  describe  the  pathways
hich  are  altered  or  modiﬁed  in  chronic  opioid  users.10--15
ration.
Group  2
(n =  15)
Group  3
(n =  15)
Group  4
(n =  15)
2.4  ±  0.9  3.4  ±  1.1  2.3  ±  1.4
4.1  ±  1.3  5.8  ±  2.3  5.3  ±  2.3
147  ±  26.4  120  ±  23.1b 139  ±  24.7










































onsidering  this  fact  that  the  relation  between  pain  percep-
ion  and  substance  abuse  is  multi-factorial,  further  study  is
eeded  to  understanding  the  underlying  mechanisms.
The  effects  of  intrathecal  addition  of  different  classes  of
pioids  to  local  anesthetics  have  been  previously  studied  in
on-addicts.  The  addition  of  fentanyl  and  sufentanil  to  con-
inuous  spinal  anesthesia  produces  effective  analgesia  with
ow  adverse  effects,16 and  intrathecal  meperidine  or  sufen-
anil  gave  good  postoperative  analgesia  in  cesarean  section
urgery.17--19
There  are  some  limitations  in  this  study.  First,  due  to
ultural  issues  in  Iran,  addict  women  rarely  agree  to  take
art  in  such  studies  due  to  the  stigmatization  that  addic-
ion  has  in  Iranian  culture.20--22 Consequently,  only  men
articipated  in  our  study.  Furthermore,  there  is  a possible
tatistical  concern  in  our  study.  The  sample  size  of  each
roup  (n  =  15)  may  be  inadequate  to  detect  any  differences
n  spinal  anesthesia  duration  in  non-addicts  and  opioid  users
ho  underwent  spinal  anesthesia  with  sufentanil  and  bupi-
acaine.  Additionally,  knowing  the  exact  daily  dose  of  opium
onsumption  in  each  of  the  patients  and  the  concentration
f  the  effective  alkaloids  in  the  opium  used  by  the  patients
as  impossible.
In  conclusion,  this  study  showed  that  the  length  of  sen-
ory  and  motor  blockade  is  shorter  in  chronic  opioid  users.
he  addition  of  5  g  of  intrathecal  sufentanil  to  hyperbaric
upivacaine  in  opium  addicts  lengthened  the  sensory  and
otor  duration  of  blockade  to  be  equivalent  to  blockade
easured  in  non-addicts.
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